GDRX Goodrx Holdings Inc

$5.03

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending
Expected on
Report Time: Unknown Release Time
The Whisper Number
Consensus Estimate:
Revenue Estimate:

Latest Earnings Insight

Updated On 10/2/2025

About Goodrx Holdings Inc

GoodRx Holdings, Inc. provides information and tools that allow consumers to compare prices and save when buying prescription drugs in the United States. The company is headquartered in Santa Monica, California.

Website: https://www.goodrx.com

Sector
TECHNOLOGY
Industry
SERVICES-COMPUTER PROCESSING & DATA PREPARATION
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1809519
Address
233 WILSHIRE BLVD., SUITE 990, SANTA MONICA, CA, US
Valuation
Market Cap
$1.72B
P/E Ratio
112.12
PEG Ratio
nan
Price to Book
2.37
Performance
EPS
$0.04
Dividend Yield
Profit Margin
2.07%
ROE
2.20%
Technicals
50D MA
$4.64
200D MA
$5.92
52W High
$9.26
52W Low
$3.82
Fundamentals
Shares Outstanding
107M
Target Price
$6.62
Beta
1.26

GDRX EPS Estimates vs Actual

Estimated
Actual

GDRX News & Sentiment

Sep 30, 2025 • Business Insider SOMEWHAT-BULLISH
Descope Extends and Closes Seed Round With $88M Total Funding, Announces Advisory Board
LOS ALTOS, Calif., Sept. 30, 2025 ( GLOBE NEWSWIRE ) -- , the drag & drop external IAM platform, today announced an extension and close of its seed financing round with $35M in new funding, bringing total funding up to $88M.
Sep 29, 2025 • Benzinga BULLISH
MacPaw Announces Jamf Marketplace Partnership and Strategic Leadership Appointments for CleanMyMac Business
Alongside this integration, MacPaw will be launching token-based deployment, making it easier than ever for IT teams to roll out CleanMyMac Business as a part of default corporate device configuration
Sep 16, 2025 • Zacks Commentary BULLISH
Hims & Hers Expands AI and Technology Focus to Advance Digital Care
HIMS boosts AI investment and appoints a new CTO as it advances personalized, technology-driven digital healthcare at scale.
Aug 21, 2025 • Motley Fool SOMEWHAT-BULLISH
The FDA Just Approved a New Use for Wegovy, and Novo Nordisk Stock is Climbing. Here's What Investors Need to Know
The famous medicine continues its impressive march forward.
Aug 19, 2025 • Benzinga NEUTRAL
Ozempic Gains First Approval In Canada For Kidney Disease And Cardiovascular Death Risk - Novo Nordisk ( NYSE:NVO )
The FLOW trial showed a 24% lower risk of kidney disease progression and deaths with Ozempic. Over 3,500 patients in 28 countries participated; trial stopped early due to strong efficacy. Get more market-moving news first with AI-powered analysis that turns noise into opportunity.
Aug 19, 2025 • Motley Fool NEUTRAL
Why Novo Nordisk Stock Popped Today
For a cheap GLP-1 weight loss stock like Novo Nordisk, almost any news can help the stock pop.
Sentiment Snapshot

Average Sentiment Score:

0.260
50 articles with scored sentiment

Overall Sentiment:

Bullish

GDRX Reported Earnings

Feb 26, 2025
Dec 31, 2024 (Pre market)
-0.01 Surprise
  • Reported EPS: $0.09
  • Estimate: $0.10
  • Whisper:
  • Surprise %: -6.2%
Nov 07, 2024
Sep 30, 2024 (Pre market)
-0.01 Surprise
  • Reported EPS: $0.08
  • Estimate: $0.09
  • Whisper:
  • Surprise %: -11.1%
Aug 08, 2024
Jun 30, 2024 (Pre market)
-0.01 Surprise
  • Reported EPS: $0.08
  • Estimate: $0.09
  • Whisper:
  • Surprise %: -11.1%
May 09, 2024
Mar 31, 2024 (Pre market)
0.0 Surprise
  • Reported EPS: $0.08
  • Estimate: $0.08
  • Whisper:
  • Surprise %: 0.0%
Feb 29, 2024
Dec 31, 2023 (Pre market)
0.01 Surprise
  • Reported EPS: $0.08
  • Estimate: $0.07
  • Whisper:
  • Surprise %: 14.3%
Nov 09, 2023
Sep 30, 2023 (Pre market)
0.0 Surprise
  • Reported EPS: $0.06
  • Estimate: $0.06
  • Whisper:
  • Surprise %: 0.0%
Aug 09, 2023
Jun 30, 2023 (Pre market)
0.01 Surprise
  • Reported EPS: $0.07
  • Estimate: $0.06
  • Whisper:
  • Surprise %: 16.7%
May 10, 2023
Mar 31, 2023 (Pre market)
0.01 Surprise
  • Reported EPS: $0.07
  • Estimate: $0.06
  • Whisper:
  • Surprise %: 16.7%
Feb 28, 2023
Dec 31, 2022 (Post market)
0.02 Surprise
  • Reported EPS: $0.07
  • Estimate: $0.05
  • Whisper:
  • Surprise %: 40.0%

Financials